🚚 Free shipping on all orders above $299 · 30 days money back guarantee · Helpline +1 251-332-4105

Letrozole 5 mg

$123.00$2.46 per tablet · 50 tablets

LETROZOLE 5MG TABLETS – Gynosure offers a PCD franchise with high margins & affordable pricing. Contact us now for the best rates and business opportunities.

Choose pack sizePrice per tablet shown

Want to order in bulk / B2B price?

Tracked, discreet delivery

Ships in discreet packaging with a tracking number. Free shipping on orders above $299.

30 days money back guarantee

Damaged, missing or only part of your order arrived? Choose a new package or a full refund.

Questions before you order?

Call +1 251-332-4105 or email order@pharmeasybank.com.

SECURE CHECKOUT
DISCOVER
MasterCard
VISA

Share

What Is Letrozole 5 mg?

Letrozole 5 mg refers to a 5 mg strength of letrozole, a nonsteroidal aromatase inhibitor that reduces estrogen production.

Letrozole is primarily used as hormonal therapy for certain types of breast cancer in postmenopausal women.

Some breast cancers depend on estrogen to grow.

These are known as hormone receptor-positive breast cancers.

Estrogen can stimulate the growth and survival of cancer cells that express estrogen receptors.

Letrozole works by inhibiting aromatase, an enzyme involved in estrogen production.

In postmenopausal women, a significant proportion of estrogen is produced through the conversion of androgens into estrogens in peripheral tissues.

By blocking aromatase, letrozole reduces circulating estrogen levels.

This can slow the growth of estrogen-dependent breast cancer cells.

Letrozole is also used off-label for ovulation induction in selected patients experiencing infertility associated with ovulatory dysfunction, including some patients with polycystic ovary syndrome (PCOS).

In fertility treatment, temporary suppression of estrogen production can stimulate hormonal signals that support ovarian follicle development.

However, oncology treatment and fertility treatment involve different treatment objectives, doses and schedules.

Important: Letrozole is not a general fertility supplement, estrogen replacement medicine or guaranteed treatment for infertility.

How Does Letrozole 5 mg Work?

1. Inhibits the Aromatase Enzyme

Letrozole selectively inhibits aromatase, an enzyme responsible for converting androgens into estrogens.

2. Reduces Estrogen Production

By inhibiting aromatase, letrozole decreases estrogen synthesis.

3. Suppresses Estrogen-Dependent Tumor Signaling

Reduced estrogen availability can decrease stimulation of hormone receptor-positive breast cancer cells.

4. Helps Slow Cancer Cell Proliferation

In appropriate patients, estrogen suppression can slow the growth of hormone-sensitive breast cancer.

5. Supports Adjuvant Breast Cancer Treatment

Letrozole may reduce the risk of recurrence when prescribed for eligible patients after primary breast cancer treatment.

6. Provides Endocrine Therapy for Advanced Breast Cancer

Letrozole may help control certain advanced or metastatic hormone receptor-positive breast cancers.

7. Alters Hormonal Feedback During Fertility Treatment

Temporary estrogen suppression can increase follicle-stimulating hormone signaling in selected patients.

8. Supports Ovulation Induction

When prescribed for appropriate patients, letrozole may stimulate ovarian follicle development and ovulation.

Important: The clinical effects of letrozole depend on the indication, hormonal status, dose and treatment schedule.

Uses of Letrozole 5 mg

1. Hormone Receptor-Positive Early Breast Cancer

Letrozole is approved for adjuvant treatment of certain postmenopausal women with hormone receptor-positive early breast cancer.

2. Extended Adjuvant Breast Cancer Therapy

Letrozole may be used after completion of an appropriate course of tamoxifen therapy in eligible postmenopausal patients.

3. Advanced Breast Cancer

Letrozole may be prescribed for selected postmenopausal patients with hormone receptor-positive or hormone receptor-unknown advanced breast cancer, according to the applicable product label.

4. Metastatic Hormone Receptor-Positive Breast Cancer

Letrozole may be used alone or as part of an appropriate combination regimen for selected patients with metastatic breast cancer.

5. Estrogen-Dependent Tumor Growth Suppression

Letrozole reduces estrogen production, helping limit hormonal stimulation of susceptible tumors.

6. Ovulation Induction

Letrozole is used off-label in some countries to induce ovulation in selected patients with anovulatory infertility.

Letrozole is recommended as a first-line pharmacological ovulation induction option for many women with PCOS-related anovulatory infertility when other infertility factors have been appropriately assessed.

8. Selected Fertility Treatment Protocols

Fertility specialists may prescribe letrozole as part of individualized ovulation induction or ovarian stimulation protocols.

Important: A 5 mg daily fertility regimen does not establish that a specific 5 mg tablet product is approved or available. Breast cancer treatment generally uses a different dosing schedule.

How to Take Letrozole Tablets

Letrozole should be taken only according to the prescribing specialist’s instructions.

General Administration Instructions

  1. Confirm the prescribed strength and indication.
  2. Take the medicine exactly as directed.
  3. Swallow the tablet with water.
  4. Letrozole can generally be taken with or without food.
  5. For daily oncology treatment, take it at approximately the same time each day.
  6. Do not increase or decrease the dose independently.
  7. Do not use fertility treatment schedules for breast cancer treatment.
  8. Attend scheduled clinical appointments.
  9. Report significant adverse effects promptly.
  10. Do not take letrozole during pregnancy.

Dosage Information

IndicationGeneral Dosage Guidance
Early Breast CancerStandard Labeled Dose: 2.5 mg Once Daily
Extended Adjuvant TherapyStandard Labeled Dose: 2.5 mg Once Daily
Advanced Breast CancerStandard Labeled Dose: 2.5 mg Once Daily
Ovulation InductionCommonly Studied Regimens Include 2.5–7.5 mg Daily for 5 Days, Under Specialist Supervision
PCOS-Related InfertilityDose and Cycle Days Determined by Fertility Specialist
Severe Hepatic ImpairmentMay Require Dose Adjustment According to Product Label
Treatment DurationDepends on Indication and Clinical Response

Important: The standard oncology dose is 2.5 mg daily. Do not substitute a 5 mg tablet for the prescribed oncology dose.

Fertility treatment requires cycle-specific instructions, assessment of pregnancy status and appropriate monitoring.

Can Letrozole Be Taken With Food?

Yes. Letrozole can generally be taken with or without food.

Can Letrozole Be Used Daily?

For breast cancer, letrozole is generally prescribed daily.

For fertility treatment, it is usually prescribed for a limited number of days within a menstrual cycle.

What If a Dose Is Missed?

Follow the prescribing instructions.

For daily treatment, take a missed dose when remembered unless it is nearly time for the next dose.

Do not double the dose.

For fertility treatment, contact the prescribing clinic because timing within the cycle matters.

What If Too Much Letrozole Is Taken?

Seek medical advice promptly.

Do not take additional tablets to compensate for missed doses.

How Long Does Letrozole Take to Work?

The time required for clinical benefit depends on the indication.

Breast Cancer Treatment

Estrogen suppression begins after treatment starts, but clinical benefit is evaluated over time.

Adjuvant Therapy

Letrozole is used over an extended period to reduce the risk of cancer recurrence in eligible patients.

Advanced Breast Cancer

Treatment response may be assessed through clinical examination, imaging and other appropriate investigations.

Ovulation Induction

The medicine is generally taken for a short course early in the menstrual cycle, followed by monitoring for follicle development and ovulation.

Important: Letrozole does not guarantee tumor response, ovulation or pregnancy.

Common Side Effects

Possible side effects include:

  • Hot Flashes
  • Joint Pain
  • Muscle Pain
  • Fatigue
  • Headache
  • Dizziness
  • Nausea
  • Increased Sweating
  • Weakness
  • Sleep Disturbances
  • Bone Pain
  • Back Pain
  • Hair Thinning
  • Peripheral Swelling
  • Increased Cholesterol
  • Vaginal Dryness
  • Mood Changes

Side effects may vary according to the indication, dose and treatment duration.

Serious Side Effects

Seek medical attention if any of the following occur:

  • Severe allergic reactions
  • Chest pain
  • Sudden shortness of breath
  • Stroke-like symptoms
  • Severe or persistent bone pain
  • Suspected fractures
  • Significant visual disturbances
  • Severe dizziness or fainting
  • Serious skin reactions
  • Symptoms of significant liver dysfunction

Important Serious Risks

1. Bone Mineral Density Reduction

Long-term estrogen suppression may reduce bone mineral density and increase fracture risk.

2. Osteoporosis

Patients receiving prolonged letrozole treatment may require bone health assessment.

3. Cardiovascular Events

Certain cardiovascular events have been reported during aromatase inhibitor treatment.

4. Increased Cholesterol

Letrozole may increase serum cholesterol levels.

5. Severe Musculoskeletal Symptoms

Some patients experience significant joint pain, muscle pain or stiffness.

6. Liver Function Abnormalities

Liver enzyme elevations and rare clinically significant liver injury may occur.

7. Embryo-Fetal Toxicity

Letrozole can harm a developing fetus and must not be used during pregnancy.

8. Severe Hypersensitivity Reactions

Serious allergic reactions require immediate medical assessment.

Contraindications & Precautions

1. Pregnancy

Letrozole can cause fetal harm and must not be taken during pregnancy.

2. Pregnancy Testing

Patients who can become pregnant should undergo appropriate pregnancy assessment before treatment.

3. Breastfeeding

Breastfeeding is not recommended during treatment and for three weeks after the final dose under U.S. labeling.

4. Contraception

Patients who can become pregnant should use effective contraception during treatment and for three weeks after the final dose, except when following a specifically supervised fertility protocol.

5. Bone Health

Long-term treatment may reduce bone mineral density.

6. Osteoporosis

Patients with osteoporosis or fracture risk factors may require bone health monitoring.

7. Cardiovascular Disease

Patients with cardiovascular risk factors should inform their healthcare professional.

8. Hypercholesterolemia

Cholesterol monitoring may be appropriate during prolonged treatment.

9. Liver Impairment

Severe liver impairment may require dose modification.

10. Kidney Impairment

Patients with significant kidney disease should inform their healthcare professional.

11. Premenopausal Hormonal Status

Letrozole is generally used for breast cancer in postmenopausal patients unless an oncology specialist prescribes it as part of an appropriate ovarian suppression regimen.

12. Fertility Treatment Monitoring

Patients undergoing ovulation induction may require ultrasound monitoring and other fertility assessments.

13. Multiple Pregnancy Risk

Ovulation induction may increase the likelihood of multiple pregnancy compared with spontaneous conception.

14. Ovarian Response

Excessive ovarian response or other fertility-related complications require specialist assessment.

15. Drug Interactions

Patients should inform their healthcare professional about all prescription medicines, supplements and hormonal therapies.

Estrogen-containing medicines may counteract the estrogen-lowering effects of letrozole.

Tamoxifen may reduce letrozole exposure and is not routinely administered concurrently.

16. Dizziness and Fatigue

Patients experiencing dizziness or fatigue should avoid driving or operating machinery until they know how the medicine affects them.

17. Long-Term Treatment

Patients receiving prolonged oncology therapy require regular assessment of treatment effectiveness and adverse effects.

18. Medical Monitoring

Healthcare professionals may monitor:

  • Treatment Response
  • Cancer Recurrence Risk
  • Bone Mineral Density
  • Fracture Risk
  • Cholesterol Levels
  • Joint Pain
  • Muscle Pain
  • Liver Function When Indicated
  • Kidney Function When Indicated
  • Cardiovascular Risk
  • Fatigue
  • Dizziness
  • Menopausal Symptoms
  • Medication Interactions
  • Treatment Adherence
  • Pregnancy Status When Relevant
  • Follicular Development During Fertility Treatment
  • Ovulation Response
  • Overall Clinical Condition

Potential Therapeutic Advantages

  • Nonsteroidal Aromatase Inhibitor.
  • Estrogen Production Suppression.
  • Hormone Receptor-Positive Breast Cancer Treatment.
  • Early Breast Cancer Adjuvant Therapy.
  • Extended Adjuvant Breast Cancer Therapy.
  • Advanced Breast Cancer Management.
  • Metastatic Breast Cancer Treatment.
  • Targeted Endocrine Therapy.
  • Oral Tablet Administration.
  • Established Aromatase Inhibition.
  • Ovulation Induction in Selected Patients.
  • PCOS-Related Anovulatory Infertility Management.
  • Individualized Fertility Treatment.
  • Specialist-Supervised Hormonal Therapy.

Disadvantages / Limitations

  • Risk of Bone Mineral Density Reduction.
  • Osteoporosis Risk.
  • Joint Pain.
  • Muscle Pain.
  • Hot Flashes.
  • Fatigue.
  • Dizziness.
  • Headache.
  • Increased Cholesterol.
  • Potential Cardiovascular Complications.
  • Pregnancy Contraindication.
  • Possible Liver Function Abnormalities.
  • Requires Medical Monitoring.
  • Fertility Use May Be Off-Label.
  • Not Suitable for Every Breast Cancer Type.
  • Does Not Guarantee Ovulation.
  • Does Not Guarantee Pregnancy.
  • Does Not Guarantee Cancer Cure.

Important Notes

Generic Name: Letrozole.

Requested Strength: 5 mg.

Common Commercial Strength: 2.5 mg.

Drug Class: Nonsteroidal Aromatase Inhibitor.

Therapeutic Category: Hormonal Anticancer Therapy.

Primary Approved Use: Selected Hormone Receptor-Positive Breast Cancer.

Additional Clinical Use: Ovulation Induction Under Specialist Supervision.

Mechanism of Action: Aromatase Inhibition.

Route: Oral.

Standard Oncology Dose: 2.5 mg Once Daily.

Fertility Dose: Individualized.

Pregnancy: Contraindicated.

Bone Health Monitoring: Important During Long-Term Treatment.

Medical Supervision: Required.

Storage: Follow Original Product Labeling.

Frequently Asked Questions

1. What is Letrozole 5 mg used for?

Letrozole is used for certain hormone receptor-positive breast cancers and is also prescribed off-label for ovulation induction in selected patients. The exact 5 mg product strength must be verified.

2. Is Letrozole a chemotherapy medicine?

Letrozole is an endocrine or hormonal anticancer medicine, not conventional cytotoxic chemotherapy.

3. How does Letrozole work?

It inhibits aromatase, reducing estrogen production.

4. Is Letrozole used for breast cancer?

Yes. It is approved for selected breast cancer indications, primarily in postmenopausal women.

5. Is Letrozole used for infertility?

Yes. It is prescribed off-label for ovulation induction in selected patients.

6. Is Letrozole used for PCOS?

Yes. Letrozole is commonly used for ovulation induction in patients with PCOS-related anovulatory infertility.

7. Is Letrozole 5 mg a standard breast cancer dose?

No. The standard labeled breast cancer dose is generally 2.5 mg once daily.

8. Can Letrozole help with ovulation?

Yes. It can stimulate ovulation in selected patients with ovulatory dysfunction.

Product DetailsInformation
Product NameLetrozole 5 mg Tablets
Generic NameLetrozole
Active IngredientLetrozole
Strength5 mg (Verify Original Packaging)
Dosage FormOral Tablets
Drug ClassNonsteroidal Aromatase Inhibitor
Therapeutic CategoryHormonal Therapy / Oncology Medicine
Primary Approved UseHormone Receptor-Positive Breast Cancer in Postmenopausal Women
Additional Clinical UseOvulation Induction in Selected Patients, Where Prescribed Off-Label
Mechanism of ActionInhibition of Aromatase Enzyme and Reduction of Estrogen Production
Route of AdministrationOral
Standard Breast Cancer Dose2.5 mg Once Daily
Fertility Treatment DoseIndividualized, Short-Course Regimen Under Specialist Supervision
Brand ReferenceFemara (Commonly Available as 2.5 mg Tablets)
ManufacturerVerify Original Packaging
Pack SizeVerify Original Packaging
Prescription StatusPrescription Medicine
StorageFollow Manufacturer Instructions
Medical SupervisionOncologist or Fertility Specialist Required
Pack sizes50 tablets, 100 tablets, 150 tablets
Bulk / B2B price inquiry

Tell us what you need and we’ll reply by email.